Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma

被引：0
|
作者：
Ganessan Kichenadasse
Jim Henry Hughes
John O. Miners
Arduino A. Mangoni
Andrew Rowland
Ashley M. Hopkins
Michael J. Sorich
机构：
[1] Flinders University,Department of Clinical Pharmacology, College of Medicine and Public Health
[2] Flinders Medical Centre/Flinders University,Department of Medical Oncology, Flinders Centre for Innovation in Cancer
[3] University of South Australia,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 85卷
关键词：
Vemurafenib; Melanoma; Threshold concentration; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：615 / 620
页数：5
相关论文
共 50 条
  • [1] Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma
    Kichenadasse, Ganessan
    Hughes, Jim Henry
    Miners, John O.
    Mangoni, Arduino A.
    Rowland, Andrew
    Hopkins, Ashley M.
    Sorich, Michael J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (03) : 615 - 620
  • [2] Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance
    Funck-Brentano, E.
    Alvarez, J. C.
    Longvert, C.
    Abe, E.
    Beauchet, A.
    Funck-Brentano, C.
    Saiag, P.
    ANNALS OF ONCOLOGY, 2015, 26 (07) : 1470 - 1475
  • [3] Relationship Between Apparent Systemic Clearance of Vemurafenib and Toxicity in Patients With Melanoma
    Kichenadasse, Ganessan
    Hughes, Jim Henry
    Fahmy, Alia
    Rowland, Andrew
    Sorich, Michael J.
    Hopkins, Ashley H.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (09) : 1243 - 1248
  • [4] Effect of early adverse events on response and survival outcomes of advanced melanoma patients treated with vemurafenib or vemurafenib plus cobimetinib: A pooled analysis of clinical trial data
    Hopkins, Ashley M.
    Van Dyk, Madele
    Rowland, Andrew
    Sorich, Michael J.
    PIGMENT CELL & MELANOMA RESEARCH, 2019, 32 (04) : 576 - 583
  • [5] The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trial
    Rutkowski, Piotr
    Kozak, Katarzyna
    Mackiewicz, Jacek
    Krzemieniecki, Krzysztof
    Nawrocki, Sergiusz
    Wasilewska-Tesluk, Ewa
    Kwinta, Lukasz
    Wysocki, Piotr
    Kosela-Paterczyk, Hanna
    Switaj, Tomasz
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2015, 19 (04): : 280 - 283
  • [6] Circulating Tumor DNA Measurement by Picoliter Droplet-Based Digital PCR and Vemurafenib Plasma Concentrations in Patients with Advanced BRAF-Mutated Melanoma
    Fanny Garlan
    Benoit Blanchet
    Nora Kramkimel
    Alicja Puszkiel
    Jean-Louis Golmard
    Gaelle Noe
    Nicolas Dupin
    Pierre Laurent-Puig
    Michel Vidal
    Valerie Taly
    Audrey Thomas-Schoemann
    Targeted Oncology, 2017, 12 : 365 - 371
  • [7] Survival of patients with advanced metastatic melanoma: The impact of novel therapies
    Ugurel, Selma
    Roehmel, Joachim
    Ascierto, Paolo A.
    Flaherty, Keith T.
    Grob, Jean Jacques
    Hauschild, Axel
    Larkin, James
    Long, Georgina V.
    Lorigan, Paul
    McArthur, Grant A.
    Ribas, Antoni
    Robert, Caroline
    Schadendorf, Dirk
    Garbe, Claus
    EUROPEAN JOURNAL OF CANCER, 2016, 53 : 125 - 134
  • [8] Circulating Tumor DNA Measurement by Picoliter Droplet-Based Digital PCR and Vemurafenib Plasma Concentrations in Patients with Advanced BRAF-Mutated Melanoma
    Garlan, Fanny
    Blanchet, Benoit
    Kramkimel, Nora
    Puszkiel, Alicja
    Golmard, Jean-Louis
    Noe, Gaelle
    Dupin, Nicolas
    Laurent-Puig, Pierre
    Vidal, Michel
    Taly, Valerie
    Thomas-Schoemann, Audrey
    TARGETED ONCOLOGY, 2017, 12 (03) : 365 - 371
  • [9] Monitoring of plasma concentrations of dabrafenib and trametinib in advanced BRAFV600mut melanoma patients
    Raynal, M.
    Alvarez, J. -C.
    Saiag, P.
    Beauchet, A.
    Funck-Brentano, C.
    Funck-Brentano, E.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2022, 149 (01): : 32 - 38
  • [10] Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications
    Mandel, Victor Desmond
    Medri, Matelda
    Manganoni, Ausilia Maria
    Pavoni, Laura
    De Rosa, Francesco
    Ribero, Simone
    Foca, Flavia
    Andreis, Daniele
    Mazzoni, Laura
    Magi, Serena
    Farnetani, Francesca
    Palla, Marco
    Ulivi, Paola
    Stanganelli, Ignazio
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1368 - 1375
12345